News
Circle Pharma receives US FDA orphan drug designation for its CID-078 to treat small cell lung cancer: South San Francisco, California Wednesday, June 18, 2025, 18:00 Hrs [IST] So ...
FDA recommends inclusion of patients as young as 6 months - younger than Moleculin had proposed - to be allowed in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback